Do not yet count Eli Lilly's Oral GLP-1 medication for obesity and diabetes, according to Jim Cramer of CNBC. It…
CNBC's Jim Cramer explained Monday why he's optimistic Interactive take-twosaying he's ready to dominate the video game space now that…